Investor insights
Sectors invested in
Biotechnology6
Health Care4
Clinical Trials3
Product Commercialization2
Therapeutics2
Biopharma2
Drug Discovery2
Regulatory Affairs2
Rare Diseases2
Clinical Development2
targeted therapy1
hematology1
Precision therapy1
Bioinformatics1
oncology1
rare diseases1
blood disorders1
Medical1
drug design1
molecular targeting1
Funding rounds participated in
$325M sweet spot round size
Most of their 7 investments are in rounds between $111M and $350M
Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Manufacturing
Date founded
1996
Investments made
A
Ascendis Pharma raised $150M on September 5, 2023
Investors: Royalty Pharma
C
Cytokinetics raised $450M on July 1, 2022
Investors: Royalty Pharma
B
Blueprint Medicines raised $1.3B on June 30, 2022
Investors: Sixth Street and Royalty Pharma
U
Undisclosed raised $111M on May 18, 2022
Investors: Leucadia National Corporation and Royalty Pharma
B
BioCryst Pharmaceuticals, Inc. raised $350M on November 22, 2021
Investors: OMERS and Royalty Pharma
B
BioCryst Pharmaceuticals, Inc. raised $325M on December 7, 2020
Investors: Athyrium Capital Management, LP and Royalty Pharma
E
Epizyme raised $100M on November 7, 2019
Investors: Royalty Pharma